Trials / Completed
CompletedNCT03664362
The BSHAPE Intervention Program for Safety and Health of Survivors of Cumulative Trauma
Cumulative Victimization and Women's Health Risks: Development of an Intervention
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 144 (actual)
- Sponsor
- Johns Hopkins University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The goal of the BSHAPE study is to test a trauma informed, culturally tailored, multicomponent program entitled BSHAPE (Being Safe, Healthy, And Positively Empowered) for immigrant survivors of cumulative trauma.
Detailed description
The central hypothesis is that the BSHAPE intervention will promote immigrant women's safety and health (e.g..,improved mental health, reduced physiological impact of stress and health inequities (especially reproductive-sexual health and HIV)), thus leading to overall empowerment. The study will: 1. Conduct a feasibility and acceptability evaluation of the BSHAPE intervention. 2. Test the BSHAPE intervention for large scale implementation in community-based clinics and programs serving immigrant women. The impact of BSHAPE will be evaluated in comparison to usual care in promoting safety and health outcomes among immigrant women with cumulative trauma experiences at post-intervention and at 6 and 12 months follow up.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | The BSHAPE Intervention | The BSHAPE intervention program key elements include strengths based assessments, individualized plans and support based on priorities and needs, motivational interviewing strategies, psychoeducation (education with skill building exercises), mindfulness activities, danger assessment, safety planning, behavioral activation and linkage to community resources |
Timeline
- Start date
- 2018-10-10
- Primary completion
- 2022-02-19
- Completion
- 2022-02-19
- First posted
- 2018-09-10
- Last updated
- 2023-05-26
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03664362. Inclusion in this directory is not an endorsement.